FDA Crackdown on Compounded GLP-1s (Regulatory): On February 6, 2026, the FDA announced a formal intent to restrict the use of active pharmaceutical ingredients (APIs) for non-approved compounded GLP-1 drugs, targeting "mass-marketed" alternatives from companies like Hims & Hers as the national supply of brand-name versions stabilized
It's imperative that those living with obesity receive the support and care they rightly deserve," stated Priti Chawla, Executive Director of Obesity Matters
How to prepare Once the IV is inserted, there shouldnt be a great deal of discomfort
This is more learn to coach yourself than actual one-on-one coaching, but the content is unique and well-done
Level D : pharmacovigilance disproportionality analyses (hypothesis-generating
Jolene Brighten, board-certified naturopathic endocrinologist, FABNE, Menopause Society Certified Practitioner (MSCP), nutrition scientist, and certified sex counselor